Literature DB >> 10830190

High incidence of acute myositis with type A influenza virus infection in the elderly.

M Yoshino1, S Suzuki, K Adachi, M Fukayama, T Inamatsu.   

Abstract

We describe six elderly cases of acute myositis with type A influenza virus infection (Sydney) during the 1998-1999 outbreak. All six cases suffered from myalgia or muscle weakness especially in the lower extremities and the serum creatine kinase (CK) values were elevated above 1,000 IU/l without MB isoenzymes or electrocardiogram abnormalities. There have been a few case reports of acute myositis associated with influenza virus infection in the elderly. However, we noticed a high incidence of acute myositis among elderly patients with type A influenza virus infection. This complication may occur more commonly in elderly patients than has previously been thought.

Entities:  

Mesh:

Year:  2000        PMID: 10830190     DOI: 10.2169/internalmedicine.39.431

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  12 in total

1.  Pandemic flu: clinical management of patients with an influenza-like illness during an influenza pandemic. Provisional guidelines from the British Infection Society, British Thoracic Society, and Health Protection Agency in collaboration with the Department of Health.

Authors: 
Journal:  Thorax       Date:  2007-01       Impact factor: 9.139

2.  Two-dimensional gel electrophoresis analysis in simultaneous influenza pneumonia and bacterial infection in mice.

Authors:  K Kosai; M Seki; K Yanagihara; S Nakamura; S Kurihara; Y Imamura; K Izumikawa; H Kakeya; Y Yamamoto; T Tashiro; S Kohno
Journal:  Clin Exp Immunol       Date:  2008-03-12       Impact factor: 4.330

Review 3.  Bacterial, fungal, parasitic, and viral myositis.

Authors:  Nancy F Crum-Cianflone
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

Review 4.  Diminished immune responses with aging predispose older adults to common and uncommon influenza complications.

Authors:  Spencer R Keilich; Jenna M Bartley; Laura Haynes
Journal:  Cell Immunol       Date:  2019-10-10       Impact factor: 4.868

5.  Three cases of acute myositis in adults following influenza-like illness during the H1N1 pandemic.

Authors:  Summer Bell Gibson; Jennifer Juhl Majersik; A Gordon Smith; Mark B Bromberg
Journal:  J Neurosci Rural Pract       Date:  2013-01

6.  Nonbacterial myositis.

Authors:  Nancy F Crum-Cianflone
Journal:  Curr Infect Dis Rep       Date:  2010-09       Impact factor: 3.725

7.  Aging augments the impact of influenza respiratory tract infection on mobility impairments, muscle-localized inflammation, and muscle atrophy.

Authors:  Jenna M Bartley; Sarah J Pan; Spencer R Keilich; Jacob W Hopkins; Iman M Al-Naggar; George A Kuchel; Laura Haynes
Journal:  Aging (Albany NY)       Date:  2016-04       Impact factor: 5.682

Review 8.  The hidden burden of influenza: A review of the extra-pulmonary complications of influenza infection.

Authors:  Subhashini A Sellers; Robert S Hagan; Frederick G Hayden; William A Fischer
Journal:  Influenza Other Respir Viruses       Date:  2017-09       Impact factor: 4.380

9.  Severe pneumonia associated with pandemic (H1N1) 2009 outbreak, San Luis Potosí, Mexico.

Authors:  Alejandro Gómez-Gómez; Martin Magaña-Aquino; Christian Garcia-Sepúlveda; Uciel R Ochoa-Pérez; Reynaldo Falcón-Escobedo; Andreu Comas-García; Saray Aranda-Romo; Hugo I Contreras-Treviño; Paulina V Jimenéz-Rico; Mario A Banda-Barbosa; Félix Dominguez-Paulin; J Mario Bernal-Blanco; Luis F Peréz-González; Daniel E Noyola
Journal:  Emerg Infect Dis       Date:  2010-01       Impact factor: 6.883

10.  Productive infection of human skeletal muscle cells by pandemic and seasonal influenza A(H1N1) viruses.

Authors:  Marion Desdouits; Sandie Munier; Marie-Christine Prevost; Patricia Jeannin; Gillian Butler-Browne; Simona Ozden; Antoine Gessain; Sylvie Van Der Werf; Nadia Naffakh; Pierre-Emmanuel Ceccaldi
Journal:  PLoS One       Date:  2013-11-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.